Free Trial
Notice: This company recently went public with an IPO on Friday, February 14th 2025. They issued 5,900,000 shares at $16.00-$18.00 per share. We will continue to update data for AARD as it becomes available.

Aardvark Therapeutics (AARD) Income Statement & Balance Sheet

$14.02 -3.23 (-18.72%)
As of 02/21/2025 03:57 PM Eastern

Aardvark Therapeutics Income Statement, Balance Sheet and Cash Flow Statement



This page (NASDAQ:AARD) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners